TABLE 1.

Clinical characteristics of study subjects

Patient codeHLA class I typeViral load (copies/ml)CD4 count (cells/μl)Opportunistic diseasea
HLA AHLA BHLA Cw
PR 12, 335, 444, 712,90012MAC infection, AIDS dementia
PR 223, 687, 57724,40055HIV wasting
PR 31, 38, 58725,362329
PR 424, 3013, 406, 730,000290
PR 53, 2542, 57348,700408
PR 624, 687, 137, 850,600488
PR 729, 3135, 402, 461,00029
PR 82, 1135, 403, 496,100436
PR 92, 3049, 517, 1698,500423
PR 1033, 6815, 533, 498,80028PCP
PR 111, 215, 532, 6118,00027KS
PR 121, 215, 443, 5124,00082PCP
PR 1318, 576, 7160,00060
PR 141, 377171,000277KS
PR 152, 2638, 445, 12200,000150
PR 161, 218, 272, 12249,000115KS
PR 172, 687, 447269,000220
PR 182, 268, 445, 7292,000129PML
PR 192, 2644, 455, 6376,0003MAC infection
PR 2030, 3635, 586, 7>500,0000
PR 2129, 6840, 522, 15>500,00011PCP
PR 222, 2418, 354, 7>500,00017Cryptococcal meningitis
PR 232, 6615, 4114, 17>750,00033Oral candidiasis
PR 241, 37, 576, 7>750,00024PCP
  • a MAC, Mycobacterium avium complex; PCP, Pneumocystis carinii pneumonia; KS, Kaposi's sarcoma; PML, progressive multifocal leukoencephalopathy; ∅, no opportunistic diseases.